MedTrace Logo

About Oral and Gut Microbiota in Intensive Care Unit : SARS-CoV-2 (COVID-19) Infection Impact.

NCT04913142 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2023-10-17

No results posted yet for this study

Summary

The objective of the present study is to describe the negative impact on oral and gut microbiota of a severe acute respiratory syndrome SARS-CoV-2 infection in patients hospitalized in intensive care units (ICU). The study would like to compare their microbiota to the microbiota of ICU patients, non-infected by the SARS-CoV-2.

Conditions

  • SARS-CoV-2 Acute Respiratory Disease

Interventions

OTHER

Fecal and oral samples

oral and rectal swab from patients hospitalized at day 1, each 7 days and at the end of their ICU stay

Sponsors & Collaborators

  • University Hospital, Toulouse

    lead OTHER

Principal Investigators

  • Fanny BOUNES, MD · University Hospital, Toulouse

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-15
Primary Completion
2025-02-15
Completion
2025-02-15

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04913142 on ClinicalTrials.gov